Ochsner Health is the leading nonprofit healthcare provider in the Gulf South. Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate.
Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.
Read MoreHistotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes primary liver tumors originating in the liver, or metastasized tumors resulting from another cancer spreading to the liver. Histotripsy is a new option for patients with liver tumors who may not be a candidate for surgery or other traditional therapies.
Read MoreEntitled “Real-world data and clinical experience from over 100,000 multi-cancer early detection tests,” the study was recently published in Nature Communications.
Read MoreOchsner LSU Health has welcomed four new specialists, further expanding access to care in the Shreveport-Bossier area and surrounding communities. These physicians, representing a variety of specialties, will also contribute to medical education as part of the LSU Health Shreveport faculty.
Read MoreThe QOPI® Certification Program builds on ASCO’s Quality Oncology Practice Initiative, providing a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.
Read MoreThe Genetic Wellness Assessment allows individuals to determine whether they may have a higher genetic risk of developing cancer by answering a few simple questions that evaluate individual risk factors.
Read MoreThe Genetic Wellness Assessment allows individuals to determine whether they may have a higher genetic risk of developing cancer by answering a few simple questions that evaluate individual risk factors. Those identified as having a high risk, or anyone interested in further evaluation, can schedule an appointment to discuss genetic testing. The results of genetic testing are used by healthcare providers to offer personalized recommendations for cancer screening, prevention and further evaluation for patients and family members.
Read MoreThis partnership brings together longstanding commitment to community healthcare, an extensive regional network and world-renowned cancer expertise to provide patients in Slidell and surrounding areas with access to advanced oncology treatments, innovative select clinical trials and the compassionate care that patients of the Slidell Regional Cancer Center know and trust.
Read MoreOchsner LSU Health proudly welcomes Dr. Katherine Chang, a fellowship-trained ENT specialist, to Feist-Weiller Cancer Center. With expertise in head and neck oncology and microvascular surgery, Dr. Chang is double board-certified and dedicated to providing compassionate, high-quality care.
Read MoreOchsner LSU Health proudly welcomes Dr. Abdulrahman Hesham, DDS, MS, a board-certified oral and maxillofacial surgeon specializing in advanced surgeries of the mouth, face, and jaw. Renowned for his expertise in treating head and neck cancers, Dr. Hesham utilizes cutting-edge techniques like microvascular free flaps and virtual surgical planning to optimize cancer treatment outcomes and functionality.
Read More